CYCLERION THERAPEUTICS, INC. Accumulated Other Comprehensive Income
CYCLERION THERAPEUTICS, INC. (CYCN) had Accumulated Other Comprehensive Income of $0 as of 2024-12-31, per its 10-K/A filed 2025-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-11-12
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$16.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2024-12-31 | $0.00 10-K/A · filed 2025-11-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$16.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$12.00K 10-K/A · filed 2025-11-12 |
| 2023-09-30 | -$18.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$16.00K 10-Q · filed 2023-07-28 |
| 2023-03-31 | -$19.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$20.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$28.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$25.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$24.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$23.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | -$26.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$26.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | -$27.00K 10-Q · filed 2021-04-30 |
| 2020-12-31 | -$27.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | -$27.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$30.00K 10-Q · filed 2020-08-03 |
| 2020-03-31 | -$18.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | -$20.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$4.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |